Sinus Lift With Hydroxyapatite Nano Particles Versus Tenting Technique

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

twenty recruited patients indicated for sinus augmentation and immediate implant placement will be divided into two groups (10 in each of the two groups), to compare bone formation and implant stability after shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles [Nanostreams] or augmentation with graft less tenting technique with simultaneous implant placement.

See also
Status	Clinical Trial	Phase
Completed	`NCT05777239` - Dental Implant Approach for Crestal Sinus Elevation; A Novel Technique.	N/A
Not yet recruiting	`NCT03731650` - Non-grafted Maxillary Sinus Floor Elevation With Simultaneous Implant Placement Using Different Implant Lengths	N/A
Recruiting	`NCT04688957` - Osseodensification by Densah Burs Versus Osteotome	N/A

NCT number	NCT03177876
Study type	Interventional
Source	Cairo University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 2016
Completion date	July 2017

Sinus Lift With Hydroxyapatite Nano Particles Versus Tenting Technique

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms